Tyler Erath, Ph.D., Assistant Professor in the Department of Psychiatry, has received a K01 award from the National Institute on Drug Abuse (NIDA). This K01 award is designed to provide Dr. Erath with mentored training in implementation science to become an independent investigator focused on advancing the implementation of evidence-based treatments for stimulant use disorder (StimUD) and other substance use disorders (SUDs) in harm reduction and other community treatment and recovery settings. The proposed research plan seeks to develop hands-on experience and skills in implementation science advancing the use of contingency management, an evidence-based treatment for StimUD, in community harm-reduction settings using syringe service programs (SSPs) as a model.

Brain health research projects led by early career investigators Kathryn Morelli, Ph.D., Masayo Koide, Ph.D., M.S., and James Stafford, Ph.D., were selected to receive grant funding from the Vermont Center for Cardiovascular and Brain Health. These pilot grants aim to advance the researchers’ skills in study design, epidemiology, translational research, and using pioneering technologies.

(JANUARY 16, 2025) Amelia Gennari, M.D., Larner associate professor of geriatric medicine and associate chief for clinical affairs for the Division of Geriatrics at the University of Vermont Medical Center, spoke with Vermont Public about the importance of having an Advance Health Care Directive.

(JANUARY 15, 2025) Melissa Houser, M.D.’12, a neurodivergent family physician specializing in providing primary care to neurodivergent children and entire families, spoke with Seven Days about their medical practice, All Brains Belong VT.

(JANUARY 13, 2025) The Sector reported that new work led by Larner Professor of Psychiatry William Copeland, Ph.D., challenges the narrative that children are inherently resilient beings—that they can recover from tragedy or difficulties with ease and without consequence.